deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02551731

Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms

Sponsor: INSYS Therapeutics Inc

Conditions Spasms, Infantile
Interventions Cannabidiol Oral Solution
Updated 9 times since 2017 Last updated: Aug 21, 2018 Started: Jan 27, 2016 Primary completion: Sep 6, 2016 Completion: Sep 6, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor elected not to continue with study

Other terminated trials from INSYS Therapeutics Inc

More terminations from INSYS Therapeutics Inc

This PHASE2 trial investigates Spasms, Infantile and is currently terminated or withdrawn. INSYS Therapeutics Inc leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotActive Not Recruiting~May 2017 – ~Mar 2018 · 10 months · monthly snapshotActive Not Recruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotTerminated~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotTerminated~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Oct 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jun 2018 — Oct 2018 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Mar 2018 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

  2. May 2017 — Mar 2018 [monthly]

    Active Not Recruiting PHASE2

  3. Feb 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • INSYS Therapeutics Inc
Data source: INSYS Therapeutics Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations